Download
s11102-020-01046-y.pdf 1,43MB
WeightNameValue
1000 Titel
  • Motivation for and adherence to growth hormone replacement therapy in adults with hypopituitarism: the patients‘ perspective
1000 Autor/in
  1. Kreitschmann-Andermahr, Ilonka |
  2. Siegel, Sonja |
  3. Unger, Nicole |
  4. Streetz-van der Werf, Christine |
  5. Karges, Wolfram |
  6. Schilbach, Katharina |
  7. Schröder, Bernadette |
  8. Szybowicz, Janine |
  9. Sauerwald, Janina |
  10. Zopf, Kathrin |
  11. Grzywotz, Agnieszka |
  12. Bidlingmaier, Martin |
  13. Sommer, Heide |
  14. Strasburger, Christian J. |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-05-21
1000 Erschienen in
1000 Quellenangabe
  • 23(5):479-487
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s11102-020-01046-y |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426293/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Introduction!#!While reasons for non-adherence in children requiring growth hormone (GH) replacement (GH-Rx) are well researched, few studies have investigated adherence in adult GH deficient patients. Against the background of the adverse medical sequelae of untreated severe GH deficiency (GHD) in adults, we explored adherence to GH-Rx and associated factors in this patient group.!##!Method!#!Cross-sectional analysis including 107 adult patients with severe GHD on GH-Rx, 15 untreated GDH patients and 19 who had discontinued therapy. Patients completed self-developed ad hoc surveys on adherence to medication and GH-Rx, specific beliefs about GH-Rx, side effects and burden of injection, reasons for never receiving or dropping out of therapy, respectively.!##!Results!#!Adherence to GH-Rx was high (mean 15.8/18 points on the self-developed adherence score) and significantly correlated with general medication adherence. Higher age was significantly associated with better adherence to GH-Rx, while injection side effects, duration of treatment or device used were not. The most frequent reasons for not being on GH-Rx apart from medical reasons included fear of side effects, lack of belief in treatment effects and dislike of injections. In patients not on GH-Rx, the proportion of patients in employment was significantly smaller than in the treatment group, despite similar age and comorbidities.!##!Conclusions!#!Adherence to GH-Rx was high for those patients on therapy. Instead of focusing on improving adherence in those adults already on GH-Rx, efforts should be undertaken to ally fear of side effects and provide education on positive treatment effects for those eligible but not receiving therapy.
1000 Sacherschließung
lokal Surveys and Questionnaires [MeSH]
lokal Adolescent [MeSH]
lokal Growth hormone deficiency
lokal Female [MeSH]
lokal Aged [MeSH]
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Hypopituitarism/drug therapy [MeSH]
lokal Growth Hormone/therapeutic use [MeSH]
lokal Middle Aged [MeSH]
lokal Cross-Sectional Studies [MeSH]
lokal Adherence
lokal Patients’ perspective
lokal Article
lokal Male [MeSH]
lokal Hormone Replacement Therapy/methods [MeSH]
lokal Hormone Replacement Therapy/psychology [MeSH]
lokal Young Adult [MeSH]
lokal Motivation [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-6389-0261|https://frl.publisso.de/adhoc/uri/U2llZ2VsLCBTb25qYQ==|https://frl.publisso.de/adhoc/uri/VW5nZXIsIE5pY29sZQ==|https://frl.publisso.de/adhoc/uri/U3RyZWV0ei12YW4gZGVyIFdlcmYsIENocmlzdGluZQ==|https://frl.publisso.de/adhoc/uri/S2FyZ2VzLCBXb2xmcmFt|https://frl.publisso.de/adhoc/uri/U2NoaWxiYWNoLCBLYXRoYXJpbmE=|https://frl.publisso.de/adhoc/uri/U2NocsO2ZGVyLCBCZXJuYWRldHRl|https://frl.publisso.de/adhoc/uri/U3p5Ym93aWN6LCBKYW5pbmU=|https://frl.publisso.de/adhoc/uri/U2F1ZXJ3YWxkLCBKYW5pbmE=|https://frl.publisso.de/adhoc/uri/Wm9wZiwgS2F0aHJpbg==|https://frl.publisso.de/adhoc/uri/R3J6eXdvdHosIEFnbmllc3prYQ==|https://frl.publisso.de/adhoc/uri/QmlkbGluZ21haWVyLCBNYXJ0aW4=|https://frl.publisso.de/adhoc/uri/U29tbWVyLCBIZWlkZQ==|https://frl.publisso.de/adhoc/uri/U3RyYXNidXJnZXIsIENocmlzdGlhbiBKLg==
1000 Hinweis
  • DeepGreen-ID: 9f02eb990a524de88cf1dade99c4adbb ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6466484.rdf
1000 Erstellt am 2023-11-16T23:42:12.718+0100
1000 Erstellt von 322
1000 beschreibt frl:6466484
1000 Zuletzt bearbeitet 2023-12-01T04:21:34.952+0100
1000 Objekt bearb. Fri Dec 01 04:21:34 CET 2023
1000 Vgl. frl:6466484
1000 Oai Id
  1. oai:frl.publisso.de:frl:6466484 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source